Today, at the State of Technology Conference with Senator Hoeven and the Fargo Moorhead West Fargo Chamber of Commerce, Aldevron announces completing the production of a DNA-based vaccine to combat malaria under a contract with the Naval Medical Research Center (NMRC). Aldevron, a leading contract manufacturer of plasmid DNA, proteins, and antibodies, produced three plasmid DNA constructs that have been delivered to NMRC in preparation for a phase I/II challenge study.
(FARGO, ND) Aldevron, a leader in the biotechnology industry, is constantly seeking innovative labor solutions and has partnered with Mind Shift to add highly skilled individuals with Autism Spectrum Disorder (ASD) to their team.
(FARGO, ND) Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, adopts new imagery and purpose statement, “The Basis for Breakthroughs”.
Aldevron’s brand promise, “The Basis for Breakthroughs”, represents the Company's dedication to providing clients with quality products and developing true partnerships that allow them to create the next generation of breakthrough therapeutics.
(FARGO, ND) Aldevron, a leading provider of contract manufacturing services for the biopharmaceutial industry, announces the appointment of Dr. Jennifer Bath as Global Director of Client Relations. Dr. Bath’s responsibilities include overseeing the company’s worldwide client relations operations across sites in Fargo, North Dakota; Madison, Wisconsin; and Freiburg, Germany.
(FARGO, ND) Aldevron, a privately held biotechnology company, announces the hire of Andrew Erovick as our Application Developer.
(FARGO, ND) Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, today announced the appointment of Troy Brendemuhl as Controller. Mr. Brendemuhl’s responsibilities include overseeing the company’s accounting functions including accounts payable and receivable. He will also be overseeing and developing the global adminsitrative teams to support upper management in the company.
(Fargo, ND) Aldevron, a privately held biotechnology company, announces the addition of Jesse Hoeg, Naomi Lucht, Taylor Miller, Tina Roeszler, and Christopher Haugen.
Jesse Hoeg joins the organization as a QA Specialist II and will be maintaining standards, processes, and controls to support Aldevron's quality systems. Jesse graduated with a BS in Biology from the University of Minnesota.
Another addition to the QA team is Naomi Lucht as a QA Specialist II. She brings 14 years of experience with BioLife Plasma as a quality auditor, and obtained a degree in Occupational Therapy from UND.
(Fargo, ND) Aldevron announced the completion of a 4,500-square-foot expansion of its GMP and GMP-Source™ biological manufacturing facilities in Fargo, North Dakota. The project increases the company’s available production capacity by over 35%. This expansion is in response to increasing demand for Aldevron’s custom plasmid, therapeutic RNA transcript, and enzyme services, and affirms the Company's position as a global leader in contract manufacturing for the biopharmaceutical industry. Aldevron’s products are used in a wide array of gene therapy, gene editing, and immunotherapy programs.
Aldevron’s operations began in a laboratory at North Dakota State University in 1998 and have grown to include sites in Fargo, Madison, Wisconsin, and Freiburg, Germany. The Fargo site currently employs over 100 people and the company expects to increase its headcount to 130 by the end of 2016.
(FARGO, ND) Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include overseeing the company’s manufacturing and client relations operations in Fargo, ND.
“We are pleased to have Ms. Stafford assume the newly created position of Vice President and General Manager,” said Michael Chambers, President and CEO of Aldevron. “Ms. Stafford has distinguished herself over the past 2 ½ years at Aldevron as Director of Quality and Regulatory by building an outstanding quality organization, leading the company’s compliance efforts, and directly supporting our clients’ needs. Her expertise and experience will play a crucial role as we grow the company to serve the expanding biologics manufacturing market.”